Bausch + Lomb (BLCO) Stock: Buy, Sell, or Hold?
BLCO - Bausch + Lomb Corporation
$17.43
0.25 (1.46%)
▲
5d:
+4.62%
30d:
+2.23%
90d:
+7.79%
BUY
MODERATE Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Oct 28, 2026
4d
Get Alerted When BLCO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: BLCO shows positive signals but monitor for confirmation. Market pricing in 2.2% decline. Moderate conviction.
💡 BUY OPPORTUNITY: BLCO shows positive signals but monitor for confirmation. Market pricing in 2.2% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$36.22
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$22.49
22.5% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 16.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BLCO is currently trading at $17.43, which is considered extended relative to its 30-day fair value range of $16.52 to $17.33. The stock's valuation (Forward PE: 15.7) is in line with its historical norms (16.7). Remarkably, the market is currently pricing in an annual earnings decline of 2.2% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, BLCO is in a strong uptrend. The price is approaching resistance at $17.47. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: BLCO scores 66/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $19.39 (+11.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BLCO is in a strong uptrend. The price is approaching resistance at $17.47. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: BLCO scores 66/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $19.39 (+11.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$16.52 -
$17.33
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
59.5%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (66/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($19.39)
- BULLISH: Bottoming setup score 66/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$16.52 -
$17.33
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$15.47
Resistance Level
$17.47
Current Trend
Strong Uptrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
15.65
Wall Street Target
$19.39
(+11.3%)
Revenue Growth (YoY)
9.1%
Earnings Growth (YoY)
-88.6%
Profit Margin
-3.2%
Valuation Discount vs History
-2.2% cheaper
PE vs Historical
15.7 vs 16.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.2%
(market-implied from PE analysis)
1-Year Target
$17.05
(-2%)
2-Year Target
$16.67
(-4%)
3-Year Target
$16.30
(-7%)
3-Yr Target (if PE normalizes)
(PE: 16→17)
$17.40
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 37.8%)
$57.92
(+232%)
Base:
(SPY PE: 15.7, Growth: 37.8%)
$45.65
(+162%)
Bear:
(PE: 13.3, Growth: 37.8%)
$38.80
(+123%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 15.7 to 16.7
Stabilization Target:
$18.60
(+6.7%)
PE Expansion Potential:
+6.7%
Share & Embed Analysis
Last updated: October 23, 2026 3:18 AM ET
Data refreshes hourly during market hours. Next update: 4:18 AM
Data refreshes hourly during market hours. Next update: 4:18 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BLCO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
STRONG BUY
34 analysts |
$479 | 32 SELL |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$83 | 37 SELL |
|
RGEN
Repligen Corporation |
STRONG BUY
22 analysts |
$198 | 49 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
17 analysts |
$413 | 41 HOLD |
|
STVN
Stevanato Group SpA |
BUY
14 analysts |
$24 | 63 BUY |
